| 03/05/2026 6:40 AM | Silence Therapeutics (1479615) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/05/2026 6:49 AM | Silence Therapeutics (1479615) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/13/2026 5:02 AM | Griffiths Richard Ian (1846370) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/09/2026 12:16 PM | Lombard Odier Asset Management (0) USA Silence Therapeutics (1479615) Subject | Form SCHEDULE 13G/A | |
| 01/06/2026 3:15 PM | Lemus David (1717972) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/06/2026 3:15 PM | HELLUMS RHONDA LYNETTE (1766456) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/06/2026 3:15 PM | Romano Steven J. (1639860) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/06/2026 3:15 PM | MCINERNEY TIMOTHY (1226020) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/06/2026 3:15 PM | Ede-Golightly James (2048873) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/22/2025 5:02 PM | Ede-Golightly James (2048873) Reporting Silence Therapeutics (1479615) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 12/22/2025 5:03 PM | Ede-Golightly James (2048873) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for SLNCF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Silence Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 12/22/2025 5:04 PM | Ross Iain (1307218) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/22/2025 3:01 PM | Silence Therapeutics (1479615) Filer | Form 8-K/A | |
| 12/22/2025 6:32 AM | Silence Therapeutics (1479615) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/06/2025 6:53 AM | Silence Therapeutics (1479615) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/06/2025 6:38 AM | Silence Therapeutics (1479615) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/23/2025 6:45 AM | Silence Therapeutics (1479615) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2025 5:30 AM | Silence Therapeutics (1479615) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/07/2025 7:04 AM | Silence Therapeutics (1479615) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/07/2025 6:35 AM | Silence Therapeutics (1479615) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/04/2025 7:03 AM | Griffiths Richard Ian (1846370) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/31/2025 7:43 AM | Griffiths Richard Ian (1846370) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/23/2025 1:22 PM | Griffiths Richard Ian (1846370) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/16/2025 1:58 PM | Griffiths Richard Ian (1846370) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/10/2025 7:36 AM | Griffiths Richard Ian (1846370) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2025 11:31 AM | Griffiths Richard Ian (1846370) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/27/2025 6:00 AM | Silence Therapeutics (1479615) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/25/2025 9:24 AM | Griffiths Richard Ian (1846370) Filed by Silence Therapeutics (1479615) Subject | Form SCHEDULE 13D/A | |
| 06/25/2025 7:59 AM | Griffiths Richard Ian (1846370) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/20/2025 5:46 AM | Griffiths Richard Ian (1846370) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/13/2025 7:06 AM | Griffiths Richard Ian (1846370) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2025 10:21 AM | Griffiths Richard Ian (1846370) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/27/2025 7:35 AM | Griffiths Richard Ian (1846370) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/21/2025 5:49 AM | Griffiths Richard Ian (1846370) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/20/2025 3:12 PM | MCINERNEY TIMOTHY (1226020) Reporting Silence Therapeutics (1479615) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/20/2025 3:14 PM | MCINERNEY TIMOTHY (1226020) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/16/2025 5:05 AM | Silence Therapeutics (1479615) Filer | Form DEF 14A | |
| 05/16/2025 5:07 AM | Silence Therapeutics (1479615) Filer | Form ARS | |
| 05/15/2025 8:02 PM | Redmile Group, LLC (1425738) Filed by Silence Therapeutics (1479615) Subject | Form SCHEDULE 13G/A | |
| 05/08/2025 9:18 AM | Griffiths Richard Ian (1846370) Filed by Silence Therapeutics (1479615) Subject | Form SCHEDULE 13D/A | |
| 05/08/2025 7:10 AM | Silence Therapeutics (1479615) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
| 05/08/2025 7:35 AM | Silence Therapeutics (1479615) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/08/2025 6:08 AM | Griffiths Richard Ian (1846370) Reporting Silence Therapeutics (1479615) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/06/2025 7:03 AM | Silence Therapeutics (1479615) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2025 7:06 AM | Silence Therapeutics (1479615) Filer | Form PRE 14A | |